What does Exicure, Inc. do?

Jun 22 2025 07:00 PM IST
share
Share Via
Exicure, Inc. is a clinical-stage biotechnology company developing therapeutics using its Spherical Nucleic Acid technology for immuno-oncology and genetic disorders, with a market cap of $52.56 million and a recent net profit of -$7 million.
Overview:
Exicure, Inc. is a clinical-stage biotechnology company focused on developing therapeutics for immuno-oncology, genetic disorders, and other indications based on its Spherical Nucleic Acid (SNA) technology, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.

Financial Snapshot:
Most recent Net Profit: -7 Million (Quarterly Results - Dec 2024)
Market cap: USD 52.56 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -1.74
Return on Equity: -41.72%
Price to Book: 7.76

Contact Details:
Address: 2430 N. HALSTED ST., CHICAGO IL : 60614
Tel: ['1 847 6731700', '1 781 2353060']
Fax: 1 847 5566411
Website: http://www.exicuretx.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Exicure, Inc. technically bullish or bearish?
Sep 20 2025 08:03 PM IST
share
Share Via
Is Exicure, Inc. overvalued or undervalued?
Jun 25 2025 09:16 AM IST
share
Share Via
Is Exicure, Inc. technically bullish or bearish?
Jun 25 2025 09:02 AM IST
share
Share Via
Who are in the management team of Exicure, Inc.?
Jun 22 2025 10:42 PM IST
share
Share Via
How big is Exicure, Inc.?
Jun 22 2025 06:13 PM IST
share
Share Via